Integral Molecular Adds Transgenic Humanized Mice to Expand its MPS Antibody Discovery Platform Through a Partnership with Alloy Therapeutics
- Wednesday, January 5, 2022, 7:06
- Finance
- Add a comment
PHILADELPHIA, Jan. 5, 2022 /PRNewswire/ — Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, has entered into an agreement to leverage Alloy Therapeutics’ transgenic humanized ATX-Gx™ mice as an added strategy to rapidly isolate fully human…
About the Author
adminasapcorp has written 39386 stories on this site.